Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT00457951
Eligibility Criteria:
Inclusion Criteria:
1. Male and female patients (40 years of age or older) with an established diagnosis of COPD based upon medical history who are being admitted to the hospital to treat an exacerbation of COPD;
2. Normal prothrombin time and activated partial thromboplastin time; Platelet count; hemoglobin and hematocrit
Exclusion Criteria:
1. Certain diseases such as:
* asthma;
* left heart failure or pulmonary embolism;
* lung cancer;
* pneumonia
* liver or kidney disease
* blood clotting disorder
* Positive HIV or hepatitis tests
* GI bleeding, physical trauma with bleeding, any disease with bleeding within 60 days of study entry
2. Certain medications such as:
* Plavix®
* Warfarin
* Heparin therapy
* Certain antibiotics
3. Exacerbations that are too severe (requiring intubation and mechanical ventilation)
4. Women of child-bearing potential, pregnancy or breast-feeding
5. Unable or unwilling to provide informed consent and follow study procedures.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT00457951
Study Brief:
Protocol Section:
NCT00457951